Stocks in play: Intellipharmaceutics International Inc.
Announced today that its financial statements for the interim period ended May 31, 2022 and related management's discussion and analysis and accompanying Chief Executive Officer and Chief Financial Officer certificates due July 15, will not be filed by the Filing Deadline. Intellipharmaceutics International Inc. shares T.IPCI are trading unchanged at $0.12.
Read:
Innovative Food Stocks Responding to Conflict-, and Drought-Driven Food Supply Shocks
Crypto Miners Finding Success While Shifting Towards Environmentally Sustainable Operations
New Approaches Towards Immunotherapy Give Hope in Fight Against Solid Tumors
As a Major Social Media Shuffle Looms, Uptake and Value of Dogecoin (DOGE) Surges
New Regions Being Developed to Produce More Oil Amid Government’s Calls for More Output